KUBTEC Scientific, a minority woman-owned company founded in 2005, headquartered in Stratford, Connecticut, is a progressive research and technology company dedicated to designing innovative and proprietary tools that include digital cabinet X-ray imaging and irradiator systems. Our diverse range of applications includes life sciences imaging and irradiation for small animals and cells, agricultural and forestry sciences imaging, and other industrial applications developed for academic, government and industrial institutions. | KUBTEC Scientific, a minority woman-owned company founded in 2005, headquartered in Stratford, Connecticut, is a progressive research and technology company dedicated to designing innovative and proprietary tools that include digital cabinet X-ray imaging and irradiator systems.
Izon Science
Izon Science is a global leader in nanoparticle characterization, separation, and purification for Exosomes, viruses, and Lipid Nanoparticles (LNPs). Our portfolio includes TRPS and the new NPS (Pulsoid) platforms for precise particle analysis, plus qEV SEC and automated qEV-TFF, Zenco, and DXter systems—supporting workflows from discovery to cGMP-aligned manufacturing. Let’s chat about how we can best support your research. | Izon Science is a global leader in nanoparticle characterization, separation, and purification for Exosomes, viruses, and LNPs. Our portfolio includes TRPS and the new NPS (Pulsoid) platforms for precise particle analysis, plus qEV SEC and automated qEV-TFF, Zenco, and DXter systems—supporting workflows from discovery to cGMP-aligned manufacturing. Let’s chat about how we can best support your research.
Huron Technologies
Huron delivers interoperable, end-to-end digital pathology solutions that pair award-winning whole slide scanners with AI-driven analysis tools, and seamless image management. Designed for both clinical and research environments, our scalable platform accelerates diagnosis, streamlines workflows, and supports advanced disease research, all with the reliability, precision, and integration trusted by world-leading laboratories and institutions.
FujiFilm VisualSonics, Inc.
FUJIFILM VisualSonics, Inc., world leader in real-time, in vivo, micro-imaging systems, providing modalities specifically designed for preclinical cancer research. Our systems deliver outstanding image quality and resolution. These tools allow for image guided injection, fast and accurate 3D tumor sizing, biomarker analysis, and sophisticated angiogenesis / tumor perfusion quantification.
Flash Pathology
Flash Pathology develops a game-changing technology that redefines tissue imaging and cancer diagnostics. Without staining or slicing, the Flash Scanner enables rapid, high-resolution visualization of freshly excised biological samples. Our microscope provides histological information while preserving the sample for further analysis. Our system assists clinicians and researchers in visual examination of tissue topology, tissue structures and cellular morphology as part of a broader diagnostic workflow, and aims to empower faster and more precise decisions.
Daicel Life Sciences
Daicel Life Sciences provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver biologicals, including Nucleic acids, without the use of needles, LNPs or other carriers. Delivery can be SC, ID, or IM. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method. | Daicel Life Sciences provides products and services to a wide array of the Pharmaceutical market. In the area of drug delivery, our Actranza lab. device is designed to inject biological drugs intra-cellularly without the use of carriers, excipients, or vectors of any kind. In animal studies, this unique needle-free injector has been proven to deliver mRNA and DNA into the cell and achieve production of the desired protein or antibody. | Daicel is a diversified technology company with unique capabilities that are being applied to a wide variety of applications, including Medical-grade plastics, Life-saving air bags, Engineered plastics, and the products of our Life Science SBU. Daicel’s Life Sciences SBU provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver RNA and DNA vaccines intracellularly without the use of needles, LNPs or other carriers. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method.
Curiosis
Curiosis Inc. is dedicated to developing, producing, and supplying innovative systems for cell-based analysis and lab automation. Our advanced solutions are designed to enhance the efficiency, precision, and scalability of cell-based research, helping scientists and medical professionals achieve better outcomes. We strive to establish ourselves as a leader in the bioindustry, focusing on delivering products that meet the evolving needs of both scientific and medical communities. By integrating cutting-edge technologies and fostering continuous innovation, we aim to make significant contributions to the advancement of biomedical research and the improvement of global healthcare outcomes.
BloodScan Biotech Inc.
BloodScan Biotech Inc. is a biotechnology company dedicated to precision oncology. Founded through technology transfer from a research team at the University of Michigan, BloodScan focuses on advancing innovations in liquid biopsy with the goal of becoming a key global driver in early cancer detection and disease monitoring. Our flagship product, Labyrinth One, is the world’s only liquid biopsy system capable of achieving tissue-biopsy-comparable performance. The system enables stable, fully automated enrichment of circulating tumor cells (CTCs) and delivers ultra-sensitive capabilities for early cancer screening and monitoring. Three Core Advantages: 1. Reliable CTC Isolation and Monitoring in Advanced Cancer – Enables disease monitoring and treatment response assessment in late-stage patients. 2. Tissue-Biopsy-Comparable Performance – Provides accuracy and biological integrity comparable to conventional histopathology. 3. Ultra-Sensitive Early Cancer Screening – Enhances early cancer detection rates to support more precise and timely treatment decisions. Our vision is to establish CTCs as a central pillar of next-generation cancer diagnostics, empowering healthcare systems worldwide to deliver earlier, more precise, and more personalized cancer care. | BloodScan Biotech Inc. Pioneering Liquid Biopsy for Precision Oncology BloodScan Biotech Inc. is a biotechnology company at the forefront of next-generation liquid biopsy technologies, committed to transforming cancer diagnostics through precision medicine. Established in 2023 as a spin-off from the University of Michigan, BloodScan focuses on advancing circulating tumor cell (CTC) isolation to improve early cancer detection, real-time treatment monitoring, and personalized therapeutic decision-making. The heart of BloodScan’s innovation is the Labyrinth One – Automated CTC Enrichment System, a compact, benchtop platform designed for high-throughput, label-free isolation of viable CTCs directly from blood samples. Unlike traditional antibody-based capture technologies, Labyrinth One utilizes microfluidic separation to deliver exceptional purity, recovery, and reproducibility—all within a 15-minute workflow. This allows for seamless integration into both clinical and research laboratory settings, enabling routine use of CTCs for diagnostics and translational oncology research. BloodScan’s mission is to bridge the gap between academic innovation and clinical implementation. Through strategic partnerships with research institutes, oncology centers, and clinical laboratories, the company aims to accelerate the adoption of liquid biopsy technologies and expand access to non-invasive cancer diagnostics that can meaningfully improve patient outcomes.
Biocare Medical
Biocare Medical, LLC is an innovator in developing and supplying world class automated immunohistochemistry instrumentation, and the full range of reagents for IHC lab testing. Biocare is the market leader in simultaneous Multiplex IHC tests which provide increased confidence at critical diagnostic decision points, impacting patient therapy while accelerating turnaround time. Biocare’s advanced micro-polymer™ detection enables unsurpassed specificity and sensitivity.